Does first-line treatment impact the cost-effectiveness of second-line treatment for elderly metastatic colon cancer patients?

被引：0
|
作者：
Mullins, C. Daniel
Woldemichael, Andinet
Zheng, Zhiyuan
Onukwugha, Ebere
Seal, Brian S.
Hanna, Nader
机构：
[1] Univ Maryland, Sch Pharm, Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA
[3] Amer Canc Soc, Atlanta, GA 30329 USA
[4] Bayer HealthCare Pharmaceut, Wayne, NJ USA
[5] Univ Maryland, Dept Surg, Div Gen & Oncol Surg, Baltimore, MD 21201 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.585
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
585
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Second-line treatment of patients with metastatic colorectal cancer
    Rougier, P
    Lepere, C
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S48 - S54
  • [42] BUDGET IMPACT ANALYSIS FOR THE FIRST-LINE AND SECOND-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Lachaine, J.
    Kouroukis, C. T.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A244 - A245
  • [43] A budget-impact and cost-effectiveness model for second-line treatment of major depression
    Malone, Daniel C.
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (06): : S8 - S18
  • [44] Cost-Effectiveness Analysis of Monoclonal Antibodies Associated With Chemotherapy in First-Line Treatment of Metastatic Colorectal Cancer
    Barufaldi, Laura A.
    de Albuquerque, Rita de C. R.
    do Nascimento, Aline
    Martins, Luis Felipe L.
    Zimmermann, Ivan R.
    de Souza, Mirian C.
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2023, 37 : 33 - 40
  • [45] COST-EFFECTIVENESS ANALYSIS OF FIRST-LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA IN COLOMBIA
    Nunez, S. M.
    Godoy, J., I
    Cardona, A. F.
    Otero, J. M.
    Lujan, M.
    Lopera, D.
    Carranza, H.
    Spath, A.
    Gis, P. R.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A219 - A219
  • [46] The combination of capecitabine and vinorelbine as a first-line or a second-line treatment in inoperable breast cancer patients
    Nakagawa, T.
    Saito, M.
    Kasumi, F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [47] Treatment of autoimmune hepatitis—First-line, second-line and third-line treatment
    Taubert R.
    Engel B.
    [J]. Die Innere Medizin, 2024, 65 (4) : 325 - 333
  • [48] Cost-effectiveness of novel first-line treatment regimens for tuberculosis
    Owens, J. P.
    Fofana, M. O.
    Dowdy, D. W.
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (05) : 590 - 596
  • [49] Cost-effectiveness of olanzapine in the first-line treatment of schizophrenia in China
    Zhao, Jingping
    Jiang, Kaida
    Li, Qingwei
    Zhang, Yanlei
    Cheng, Yan
    Lin, Ziyi
    Xuan, Jianwei
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (05) : 439 - 446
  • [50] Cost-effectiveness of olanzapine as a first-line treatment: A response to comment
    Tunis, Sandra L.
    Faries, Douglas E.
    Nyhuis, Allen W.
    Kinon, Bruce J.
    Ascher-Svanum, Haya
    Lilly, Eli
    Aquila, Ralph
    [J]. VALUE IN HEALTH, 2006, 9 (05) : 358 - 358
12345